Trial Condition(s):

PAD

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

Bayer Identifier:

EURO CANAL

ClinicalTrials.gov Identifier:

NCT01260870

EudraCT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

To evaluate the procedural safety and to identify and characterize therapeutic and functional endpoint assessments in subjects with documented critical limb ischemia who received treatment with the Cotavance Paclitaxel-Coated Balloon vs. those who received POBA only.

Inclusion Criteria
- Subjects with CLI
Exclusion Criteria
- Participation in another research trial
- Medical conditions the study doctor will assess

Trial Summary

Enrollment Goal
44
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Paclitaxel-coated balloon catheters
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Medical University

Graz, Austria

Status
Recruiting
 
Locations

University Hospital

Bern, Switzerland

Status
Recruiting
 
Locations

University Hospital

Zurich, Switzerland

Status
Recruiting
 
Locations

AZ St.-Blasius Hospital

Dendermonde, Belgium

Status
Recruiting
 
Locations

University Hospital

Gent, Belgium

Status
Recruiting
 
Locations

St. George's Hospital

London, United Kingdom

Status
Recruiting
 

Trial Design